Schneider Electric-Driven Bacterial Sialadenitis Market To Reach US$ 2.19 Billion By 2024
The global bacterial sialadenitis market has been growing rapidly over the past few years. Bacterial sialadenitis refers to the infection and inflammation of the salivary glands, usually caused by bacterial infections such as Staphylococcus aureus and streptococci. The rising prevalence of salivary gland disorders and increasing investment in R&D of novel therapeutic drugs and treatment procedures are majorly driving the demand for bacterial sialadenitis treatment.
Some of the commonly used drugs to treat bacterial sialadenitis include antibiotics such as penicillin, macrolides, second-generation cephalosporins, and clindamycin. Surgery to drain abscesses is also an effective treatment option in some cases.
The global bacterial sialadenitis market is estimated to be valued at US$ 2.19 Bn in 2024 and is expected to exhibit a CAGR of 6.6% over the forecast period 2024 to 2030.
Key Takeaways
Key players operating in the bacterial sialadenitis market are Schneider Electric, Eaton, Emerson Electric, Toshiba, Siemens, General Electric, Delta Electronics, Huawei, ABB, and Vertiv.
The growing prevalence of salivary gland disorders worldwide is creating high demand for advanced treatment and diagnostic procedures for bacterial sialadenitis. According to the WHO, salivary gland disorders affect about 1 in every 100 people annually.
Major players are expanding their presence globally to tap the emerging markets. For instance, in 2023, Schneider Electric plans to inaugurate a new manufacturing plant in India to address the growing demand for low-voltage power distribution equipment in the region.
Market Drivers
The increasing geriatric population is one of the major drivers of the bacterial sialadenitis market. Older adults above 60 years of age are more susceptible to salivary gland infections due to a weakened immune system. According to the UN, the number of people aged 60 years or above is expected to double by 2050 and reach around 2 billion. This is anticipated to significantly drive the need for bacterial sialadenitis diagnosis and treatment over the forecast period.
Current Geopolitical Impact on Bacterial Sialadenitis Market Growth
The Bacterial Sialadenitis Market Size is witnessing changes due to rising geopolitical tensions and economic uncertainties across various regions. The ongoing Russia-Ukraine conflict has disrupted global supply chains and manufacturing hubs. This has negatively impacted the Europe and APAC bacterial sialadenitis markets that source raw materials and components from Ukraine and Russia. Rising inflationary pressures and weakened currencies have also reduced purchasing power and demand in these regions.
Moreover, strict export controls and sanctions on Russia have hindered product availability for European and American companies dependent on Russian suppliers. To overcome these supply bottlenecks, companies will need to diversify sourcing bases, build local manufacturing capabilities and identify new suppliers in strategic markets like North America and select ASEAN countries. Collaborating with regional small businesses can help enhance domestic production capacities over the long-run.
Geographical Regions with High Market Concentration
North America currently accounts for the largest share of the global bacterial sialadenitis market in terms of value. This is attributed to high healthcare expenditure, robust research funding for rare diseases, and presence of major market players in the US and Canada. Availability of advanced diagnostic methods and widespread health insurance have boosted early detection and treatment rates for bacterial sialadenitis in the region.
Europe holds the second largest market position driven by public healthcare systems, growing elderly population susceptible to salivary gland disorders, and wide acceptance of innovative therapeutics. However, the ongoing geopolitical tensions may reduce Europe's market share in the short-term.
Fastest Growing Regional Market
The Asia Pacific region, especially China and India, is expected to witness the fastest growth during the forecast period. This can be attributed to rising medical tourism, increasing healthcare spending, growing focus on rare disease management, and presence of large patient pool. Favorable government policies supporting local manufacturers will offer new opportunities. Meanwhile, companies must ensure affordable pricing and invest in enhancing awareness to drive the market momentum across emerging Asian countries.
Get more insights on- Bacterial Sialadenitis Market
Check more trending articles related to this topic: Microsegmentation Market
English
Arabic
Français
Español
Português
Deutsch
Türkçe
Dutch
Italiano
Romaian